Incheon, South Korea

Min-Jung Park

USPTO Granted Patents = 14 


 

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 75(Granted Patents)


Location History:

  • Suwon-si, KR (2010 - 2020)
  • Incheon, KR (2016 - 2020)
  • Gyeonggi-do, KR (2018 - 2021)
  • Seoul, KR (2016 - 2024)

Company Filing History:


Years Active: 2010-2024

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Min-Jung Park: Innovator in Transplantation and Immune Disorders

Introduction

Min-Jung Park is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceutics, particularly in the prevention and treatment of transplant rejection and immune disorders. With a total of 14 patents to his name, his work has the potential to impact the lives of many patients undergoing transplantation.

Latest Patents

Among his latest patents is a composition for preventing and treating transplant rejection or transplant rejection diseases. This composition comprises a novel compound and a calcineurin inhibitor. The invention aims to reduce the activity of pathogenic Th1 and Th17 cells while increasing the activity of Treg cells. It also has an inhibitory effect against side effects, such as tissue damage, that may occur with conventional immunosuppressants. Additionally, it inhibits various pathogenic pathways, cell death of inflammatory cells, and increases mitochondrial activity in various models related to transplantation rejection. Another notable patent involves a method for inhibiting STAT3 activity through the administration of Ssu72 protein.

Career Highlights

Min-Jung Park has worked with notable organizations, including Samsung Electronics Co., Ltd. and The Catholic University of Korea Industry-Academic Cooperation Foundation. His experience in these institutions has allowed him to develop innovative solutions in the field of transplantation and immune response.

Collaborations

Throughout his career, Min-Jung Park has collaborated with several professionals, including Mi-La Cho and Dong-Yun Shin. These collaborations have contributed to the advancement of his research and the development of his patents.

Conclusion

Min-Jung Park is a distinguished inventor whose work in transplantation and immune disorders has the potential to revolutionize treatment options. His innovative patents reflect his commitment to improving patient outcomes in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…